Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
Diabetes mellitus (DM) increases the risk of viral infections especially during the period of poor glycemic controls. Emerging evidence has reported that DM is one of the most common comorbidities in the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection, also referred to as...
Main Authors: | Bao Sun, Shiqiong Huang, Jiecan Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.592439/full |
Similar Items
-
Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
by: Chengxia Kan, et al.
Published: (2021-09-01) -
COST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL
by: TRI MURTI ANDAYANI, et al.
Published: (2007-01-01) -
Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19
by: Hiroyuki Futatsugi, et al.
Published: (2020-10-01) -
Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients
by: Sivanandy Palanisamy, et al.
Published: (2018-06-01) -
Antidiabetic agents and cancer outcomes: Are there differences between agents?
by: Bowker, Samantha Lyndsey
Published: (2009)